Location: New York, NY
CIK: 0001826434 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value: $219M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 167,807 | $26.01M | 11.9% | $135.39 | +0.2% | COM | 00287Y109 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1,794,335 | $18.73M | 8.6% | $9.59 | — | SPONSORED ADS | 881624209 |
| KVUE | KENVUE INC | 698,800 | $15.05M | 6.9% | — | — | Put | 49177J102 |
| REGN | REGENERON PHARMACEUTICALS | 16,012 | $14.06M | 6.4% | $750.05 | +9.2% | COM | 75886F107 |
| GEHC | GE HEALTHCARE TECHNOLOGIES I | 171,676 | $13.27M | 6.1% | $71.86 | -2.9% | COMMON STOCK | 36266G107 |
| ASND | ASCENDIS PHARMA A/S | 99,550 | $12.54M | 5.7% | $125.95 | — | SPONSORED ADR | 04351P101 |
| — | AVADEL PHARMACEUTICALS PLC | 839,933 | $11.86M | 5.4% | $8.13 | — | SPONSORED ADR | 05337M104 |
| BIIB | BIOGEN INC | 45,814 | $11.86M | 5.4% | $245.62 | 0.0% | COM | 09062X103 |
| — | CATALENT INC | 261,797 | $11.76M | 5.4% | $59.71 | — | COM | 148806102 |
| AXSM | AXSOME THERAPEUTICS INC | 130,738 | $10.41M | 4.8% | $63.33 | +5.6% | COM | 05464T104 |
| XENE | XENON PHARMACEUTICALS INC | 225,564 | $10.39M | 4.7% | $36.56 | -3.4% | COM | 98420N105 |
| ARGX | ARGENX SE | 24,182 | $9.2M | 4.2% | $446.40 | — | SPONSORED ADR | 04016X101 |
| NTRA | NATERA INC | 141,847 | $8.885M | 4.1% | $51.00 | -2.1% | COM | 632307104 |
| LEGN | LEGEND BIOTECH CORP | 102,215 | $6.15M | 2.8% | $60.17 | — | SPONSORED ADS | 52490G102 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 25,524 | $5.906M | 2.7% | $180.91 | -3.3% | COM | 558868105 |
| — | VERONA PHARMA PLC | 293,112 | $5.827M | 2.7% | $18.27 | — | SPONSORED ADS | 925050106 |
| PRAX | PRAXIS PRECISION MEDICINES I | 248,761 | $5.542M | 2.5% | $18.01 | 0.0% | COM NEW | 74006W207 |
| — | ASTRIA THERAPEUTICS INC | 542,945 | $4.17M | 1.9% | $8.12 | — | COM | 04635X102 |
| AZN | ASTRAZENECA PLC | 58,787 | $3.959M | 1.8% | $67.63 | — | SPONSORED ADR | 046353108 |
| SRRK | SCHOLAR ROCK HLDG CORP | 207,147 | $3.894M | 1.8% | $12.43 | 0.0% | COM | 80706P103 |
| ARCT | ARCTURUS THERAPEUTICS HLDGS | 110,470 | $3.483M | 1.6% | $30.81 | -22.8% | COM | 03969T109 |
| IMTX | IMMATICS N.V | 275,482 | $2.901M | 1.3% | $11.23 | -18.1% | SHS | N44445109 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 47,604 | $2.875M | 1.3% | $55.20 | -6.6% | CLASS A ORD | 61559X104 |
| FEMY | FEMASYS INC | 36,150 | $35,246 | 0.0% | $6.64 | -81.5% | COM | 31447E105 |